focus -WSS

focus

author：entertainment 2025-09-30 09:29:48 - browse：1

U.S. Sen. John Thune (R-SD) arrives for a Senate Republican meeting at the U.S. Capitol on February 08, 2024 in Washington, DC. — Senate Minority Whip John Thune is one member of a bipartisan group working to develop Medicare physician payment reforms. Kevin Dietsch/Getty Images

WASHINGTON — A bipartisan group of senators is starting work on legislation to reform how Medicare pays physicians, they will announce Friday.

Senate Minority Whip John Thune (R-S.D.) and Sens. Marsha Blackburn (R-Tenn.), John Barrasso (R-Wyo.), Debbie Stabenow (D-Mich.), Mark Warner (D-Va.), and Catherine Cortez Masto (D-Nev.) announced their intent to develop long-term fixes to issues with Medicare’s physician payment structure and to update the Medicare Access and CHIP Reauthorization Act.

“Further action is needed to address reimbursement challenges and shift toward a system that aligns payment incentives with patient outcomes,” they said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： CDC concerned about possible undetected monkeypox spread in U.K.

leisure time

focus

WSS

New guidelines on severe brain injury complicate already difficult decisions

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

The battle over the Brookhaven Landfill on Long Island

CDC advisory panel says seniors 'may' get RSV vaccine

Disclosing genetic information: not as worrisome as once feared

leisure time

focus

hotspot

Drug repurposing or repositioning? The language matters

In areas with more Black doctors, Black people live longer

How one medical school became remarkably diverse

New guidelines on severe brain injury complicate already difficult decisions

How to save PrEP access — and even expand it

Weight bias in eating disorder treatment complicated by new weight loss drugs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

United colonoscopy coverage change 'may cost lives,' doctors say

The strategy behind pharma's lawsuits over drug pricing reform

knowledge

The strategy behind pharma's lawsuits over drug pricing reform

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Appeals court upholds limits to abortion pill

In science, is the line between industry and academia shifting?

With FDA staff opposed to Sarepta therapy, top official intervened

Psilocybin's anti

focus

leisure time

focus

leisure time